Does IDELALISIB Cause Diffuse large b-cell lymphoma? 28 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 28 reports of Diffuse large b-cell lymphoma have been filed in association with IDELALISIB (Zydelig). This represents 0.4% of all adverse event reports for IDELALISIB.
28
Reports of Diffuse large b-cell lymphoma with IDELALISIB
0.4%
of all IDELALISIB reports
5
Deaths
5
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma From IDELALISIB?
Of the 28 reports, 5 (17.9%) resulted in death, 5 (17.9%) required hospitalization.
Is Diffuse large b-cell lymphoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IDELALISIB. However, 28 reports have been filed with the FAERS database.
What Other Side Effects Does IDELALISIB Cause?
Disease progression (1,204)
Death (779)
Diarrhoea (752)
Off label use (548)
Pneumonia (426)
Pyrexia (371)
Drug ineffective (294)
Fatigue (284)
Dehydration (242)
Dyspnoea (206)
What Other Drugs Cause Diffuse large b-cell lymphoma?
RITUXIMAB (1,571)
CYCLOPHOSPHAMIDE (1,183)
PREDNISONE (1,062)
METHOTREXATE (1,055)
VINCRISTINE (1,043)
DOXORUBICIN (1,002)
LENALIDOMIDE (779)
TACROLIMUS (595)
DEXAMETHASONE (539)
PREDNISOLONE (506)
Which IDELALISIB Alternatives Have Lower Diffuse large b-cell lymphoma Risk?
IDELALISIB vs IDURSULFASE
IDELALISIB vs IFOSFAMIDE
IDELALISIB vs IGURATIMOD
IDELALISIB vs ILOPERIDONE
IDELALISIB vs ILOPROST